SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
- Freie Universität, Berlin (Germany); Humboldt University of Berlin (Germany); German Center for Neurodegenerative Diseases (DZNE), Berlin (Germany); Helmholtz Innovation Laboratory BaoBab (Brain Antibody-omics and B-cell Laboratory), Berlin (Germany)
- Scripps Research Institute, La Jolla, CA (United States)
- Freie Universität, Berlin (Germany); Humboldt University of Berlin (Germany); German Center for Neurodegenerative Diseases (DZNE), Berlin (Germany)
- Freie Universität, Berlin (Germany); Humboldt University of Berlin (Germany); German Centre for Infection Research (DZIF), Berlin (Germany); Labor Berlin-Charité Vivantes GmbH, Berlin (Germany)
- German Center for Neurodegenerative Diseases (DZNE), Berlin (Germany); Helmholtz Innovation Laboratory BaoBab (Brain Antibody-omics and B-cell Laboratory), Berlin (Germany)
- Freie Universität, Berlin (Germany); Humboldt University of Berlin (Germany); German Centre for Infection Research (DZIF), Berlin (Germany)
- Helmholtz Innovation Laboratory BaoBab (Brain Antibody-omics and B-cell Laboratory), Berlin (Germany)
- Charité–Universitätsmedizin, Berlin (Germany)
- Freie Universität, Berlin (Germany); Humboldt University of Berlin (Germany)
- Medical Center of the University of Munich (LMU) (Germany); German Center for Infection Research (DZIF), Munich (Germany)
- BKH Schwaz (Austria)
- Medical University of Innsbruck (Austria)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant of concern (VOC) resists neutralization by major classes of antibodies from COVID-19 patients and vaccinated individuals. In this study, serum of Beta-infected patients revealed reduced cross-neutralization of wild-type virus. From these patients, we isolated Beta-specific and cross-reactive receptor-binding domain (RBD) antibodies. The Beta-specificity results from recruitment of VOC-specific clonotypes and accommodation of mutations present in Beta and Omicron into a major antibody class that is normally sensitive to these mutations. The Beta-elicited cross-reactive antibodies share genetic and structural features with wild type–elicited antibodies, including a public VH1-58 clonotype that targets the RBD ridge. These findings advance our understanding of the antibody response to SARS-CoV-2 shaped by antigenic drift, with implications for design of next-generation vaccines and therapeutics.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States). Advanced Light Source (ALS)
- Sponsoring Organization:
- Austrian Science Fund (FWF); Bill and Melinda Gates Foundation; German Research Foundation (DFG); National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF); USDOE Office of Science (SC), Biological and Environmental Research (BER)
- Grant/Contract Number:
- AC02-05CH11231; AC02-76SF00515
- OSTI ID:
- 1982958
- Journal Information:
- Science, Journal Name: Science Journal Issue: 6582 Vol. 375; ISSN 0036-8075
- Publisher:
- AAASCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody